Grant Street Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-395
Closed -$142K 89
2021
Q1
$142K Hold
395
0.08% 59
2020
Q4
$127K Buy
+395
New +$121K 0.07% 44

Other funds holding ELV

Grant Street Asset Management's ELV Position: Q2 2021 in Review

Grant Street Asset Management sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 395 shares — an estimated $142K sold.

Grant Street Asset Management first reported a position in ELV in Q4 2020 and held it in 2 quarters. The position peaked at $142K in Q1 2021. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • Grant Street Asset Management reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • Grant Street Asset Management sold 395 Elevance Health shares in Q2 2021, an estimated $142K.
  • Grant Street Asset Management first reported a position in Elevance Health in Q4 2020 and held it in 2 quarters.
  • Grant Street Asset Management's Elevance Health position peaked at $142K in Q1 2021.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Grant Street Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.